The histone H3K4 demethylase LSD1 has been investigated as a target in Ewing sarcoma and AML, where LSD1 inhibition induces differentiation of AML cells (2) and blocks fusion protein transcriptional targets in sarcoma (3). Here, KDM1A is linked to acute myeloid leukemia.